nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—AGTR1—pancreatic cancer	0.393	1	CbGaD
Losartan—UGT2B7—Epirubicin—pancreatic cancer	0.0419	0.0962	CbGbCtD
Losartan—UGT1A1—Erlotinib—pancreatic cancer	0.039	0.0896	CbGbCtD
Losartan—UGT1A1—Irinotecan—pancreatic cancer	0.0352	0.0809	CbGbCtD
Losartan—SLCO1B3—Docetaxel—pancreatic cancer	0.0307	0.0705	CbGbCtD
Losartan—SLCO1B1—Irinotecan—pancreatic cancer	0.0244	0.056	CbGbCtD
Losartan—ALB—Erlotinib—pancreatic cancer	0.0148	0.034	CbGbCtD
Losartan—CYP3A5—Tamoxifen—pancreatic cancer	0.014	0.0321	CbGbCtD
Losartan—CYP2C8—Tamoxifen—pancreatic cancer	0.0134	0.0309	CbGbCtD
Losartan—ALB—Irinotecan—pancreatic cancer	0.0134	0.0307	CbGbCtD
Losartan—CYP1A2—Dacarbazine—pancreatic cancer	0.0131	0.03	CbGbCtD
Losartan—ALB—Fluorouracil—pancreatic cancer	0.0128	0.0294	CbGbCtD
Losartan—CYP3A5—Erlotinib—pancreatic cancer	0.0119	0.0273	CbGbCtD
Losartan—CYP2C8—Erlotinib—pancreatic cancer	0.0114	0.0263	CbGbCtD
Losartan—CYP2C19—Tamoxifen—pancreatic cancer	0.0113	0.0259	CbGbCtD
Losartan—CYP3A5—Irinotecan—pancreatic cancer	0.0107	0.0247	CbGbCtD
Losartan—CYP1A2—Tamoxifen—pancreatic cancer	0.0104	0.0239	CbGbCtD
Losartan—CYP2C8—Fluorouracil—pancreatic cancer	0.0099	0.0228	CbGbCtD
Losartan—CYP2C9—Tamoxifen—pancreatic cancer	0.00937	0.0215	CbGbCtD
Losartan—ABCB1—Tamoxifen—pancreatic cancer	0.00909	0.0209	CbGbCtD
Losartan—CYP1A2—Erlotinib—pancreatic cancer	0.00884	0.0203	CbGbCtD
Losartan—CYP3A5—Docetaxel—pancreatic cancer	0.00786	0.0181	CbGbCtD
Losartan—ABCB1—Gemcitabine—pancreatic cancer	0.00784	0.018	CbGbCtD
Losartan—CYP3A5—Sunitinib—pancreatic cancer	0.00783	0.018	CbGbCtD
Losartan—ABCB1—Erlotinib—pancreatic cancer	0.00773	0.0178	CbGbCtD
Losartan—CYP1A2—Fluorouracil—pancreatic cancer	0.00766	0.0176	CbGbCtD
Losartan—ABCB1—Irinotecan—pancreatic cancer	0.00698	0.016	CbGbCtD
Losartan—CYP2C9—Fluorouracil—pancreatic cancer	0.00691	0.0159	CbGbCtD
Losartan—CYP3A4—Tamoxifen—pancreatic cancer	0.00545	0.0125	CbGbCtD
Losartan—ABCB1—Docetaxel—pancreatic cancer	0.00512	0.0118	CbGbCtD
Losartan—ABCB1—Sunitinib—pancreatic cancer	0.00509	0.0117	CbGbCtD
Losartan—CYP3A4—Erlotinib—pancreatic cancer	0.00463	0.0106	CbGbCtD
Losartan—CYP3A4—Irinotecan—pancreatic cancer	0.00418	0.00962	CbGbCtD
Losartan—ABCB1—Doxorubicin—pancreatic cancer	0.00382	0.00877	CbGbCtD
Losartan—CYP3A4—Docetaxel—pancreatic cancer	0.00307	0.00705	CbGbCtD
Losartan—CYP3A4—Sunitinib—pancreatic cancer	0.00305	0.00701	CbGbCtD
Losartan—CYP3A4—Doxorubicin—pancreatic cancer	0.00229	0.00525	CbGbCtD
Losartan—UGT2B17—digestive system—pancreatic cancer	0.00218	0.191	CbGeAlD
Losartan—ACE—umbilical vein—pancreatic cancer	0.00169	0.148	CbGeAlD
Losartan—SLC22A12—digestive system—pancreatic cancer	0.00141	0.123	CbGeAlD
Losartan—Eprosartan—AGTR1—pancreatic cancer	0.0013	0.199	CrCbGaD
Losartan—UGT1A10—digestive system—pancreatic cancer	0.00123	0.108	CbGeAlD
Losartan—Azilsartan medoxomil—AGTR1—pancreatic cancer	0.00106	0.162	CrCbGaD
Losartan—Forasartan—AGTR1—pancreatic cancer	0.000987	0.151	CrCbGaD
Losartan—UGT1A3—digestive system—pancreatic cancer	0.000869	0.0759	CbGeAlD
Losartan—ALB—gall bladder—pancreatic cancer	0.000726	0.0634	CbGeAlD
Losartan—Tasosartan—AGTR1—pancreatic cancer	0.000598	0.0913	CrCbGaD
Losartan—Valsartan—AGTR1—pancreatic cancer	0.000519	0.0791	CrCbGaD
Losartan—Olmesartan—AGTR1—pancreatic cancer	0.000505	0.0771	CrCbGaD
Losartan—UGT2B7—digestive system—pancreatic cancer	0.000499	0.0436	CbGeAlD
Losartan—Telmisartan—AGTR1—pancreatic cancer	0.000488	0.0744	CrCbGaD
Losartan—UGT1A1—digestive system—pancreatic cancer	0.000424	0.0371	CbGeAlD
Losartan—Candesartan—AGTR1—pancreatic cancer	0.000393	0.06	CrCbGaD
Losartan—Irbesartan—AGTR1—pancreatic cancer	0.000393	0.06	CrCbGaD
Losartan—SLCO1B1—digestive system—pancreatic cancer	0.000353	0.0308	CbGeAlD
Losartan—Telmisartan—PPARG—pancreatic cancer	0.000307	0.0468	CrCbGaD
Losartan—CYP3A5—islet of Langerhans—pancreatic cancer	0.000302	0.0264	CbGeAlD
Losartan—ACE—digestive system—pancreatic cancer	0.000273	0.0239	CbGeAlD
Losartan—CYP2C19—digestive system—pancreatic cancer	0.00023	0.0201	CbGeAlD
Losartan—CYP3A5—pancreas—pancreatic cancer	0.000212	0.0185	CbGeAlD
Losartan—CYP1A2—digestive system—pancreatic cancer	0.000188	0.0164	CbGeAlD
Losartan—CYP3A5—digestive system—pancreatic cancer	0.000181	0.0158	CbGeAlD
Losartan—CYP2C9—digestive system—pancreatic cancer	0.000178	0.0156	CbGeAlD
Losartan—ABCB1—islet of Langerhans—pancreatic cancer	0.00016	0.014	CbGeAlD
Losartan—CYP3A4—digestive system—pancreatic cancer	0.000136	0.0119	CbGeAlD
Losartan—ABCB1—pancreas—pancreatic cancer	0.000113	0.00984	CbGeAlD
Losartan—Upper respiratory tract infection—Epirubicin—pancreatic cancer	9.79e-05	0.000885	CcSEcCtD
Losartan—Urticaria—Fluorouracil—pancreatic cancer	9.78e-05	0.000884	CcSEcCtD
Losartan—Headache—Sunitinib—pancreatic cancer	9.77e-05	0.000883	CcSEcCtD
Losartan—Syncope—Docetaxel—pancreatic cancer	9.76e-05	0.000882	CcSEcCtD
Losartan—Influenza—Doxorubicin—pancreatic cancer	9.75e-05	0.000881	CcSEcCtD
Losartan—Leukopenia—Docetaxel—pancreatic cancer	9.74e-05	0.000881	CcSEcCtD
Losartan—Pollakiuria—Epirubicin—pancreatic cancer	9.73e-05	0.00088	CcSEcCtD
Losartan—Body temperature increased—Fluorouracil—pancreatic cancer	9.73e-05	0.000879	CcSEcCtD
Losartan—Eosinophilia—Doxorubicin—pancreatic cancer	9.65e-05	0.000872	CcSEcCtD
Losartan—ABCB1—digestive system—pancreatic cancer	9.63e-05	0.00841	CbGeAlD
Losartan—Palpitations—Docetaxel—pancreatic cancer	9.62e-05	0.000869	CcSEcCtD
Losartan—Photosensitivity reaction—Epirubicin—pancreatic cancer	9.62e-05	0.000869	CcSEcCtD
Losartan—Weight increased—Epirubicin—pancreatic cancer	9.59e-05	0.000867	CcSEcCtD
Losartan—Loss of consciousness—Docetaxel—pancreatic cancer	9.57e-05	0.000865	CcSEcCtD
Losartan—Pancreatitis—Doxorubicin—pancreatic cancer	9.56e-05	0.000864	CcSEcCtD
Losartan—Hyperglycaemia—Epirubicin—pancreatic cancer	9.5e-05	0.000859	CcSEcCtD
Losartan—Cough—Docetaxel—pancreatic cancer	9.5e-05	0.000859	CcSEcCtD
Losartan—Angina pectoris—Doxorubicin—pancreatic cancer	9.5e-05	0.000858	CcSEcCtD
Losartan—Hypersensitivity—Irinotecan—pancreatic cancer	9.47e-05	0.000856	CcSEcCtD
Losartan—Pneumonia—Epirubicin—pancreatic cancer	9.45e-05	0.000854	CcSEcCtD
Losartan—Bronchitis—Doxorubicin—pancreatic cancer	9.38e-05	0.000847	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	9.31e-05	0.000842	CcSEcCtD
Losartan—Chest pain—Docetaxel—pancreatic cancer	9.27e-05	0.000838	CcSEcCtD
Losartan—Arthralgia—Docetaxel—pancreatic cancer	9.27e-05	0.000838	CcSEcCtD
Losartan—Myalgia—Docetaxel—pancreatic cancer	9.27e-05	0.000838	CcSEcCtD
Losartan—Nausea—Sunitinib—pancreatic cancer	9.27e-05	0.000838	CcSEcCtD
Losartan—Renal failure—Epirubicin—pancreatic cancer	9.23e-05	0.000835	CcSEcCtD
Losartan—Asthenia—Irinotecan—pancreatic cancer	9.22e-05	0.000833	CcSEcCtD
Losartan—Neuropathy peripheral—Epirubicin—pancreatic cancer	9.21e-05	0.000832	CcSEcCtD
Losartan—Jaundice—Epirubicin—pancreatic cancer	9.16e-05	0.000828	CcSEcCtD
Losartan—Conjunctivitis—Epirubicin—pancreatic cancer	9.13e-05	0.000825	CcSEcCtD
Losartan—Urinary tract infection—Epirubicin—pancreatic cancer	9.13e-05	0.000825	CcSEcCtD
Losartan—Hypersensitivity—Fluorouracil—pancreatic cancer	9.07e-05	0.00082	CcSEcCtD
Losartan—Dry mouth—Docetaxel—pancreatic cancer	9.06e-05	0.000819	CcSEcCtD
Losartan—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	9.06e-05	0.000819	CcSEcCtD
Losartan—Sweating—Epirubicin—pancreatic cancer	9.01e-05	0.000814	CcSEcCtD
Losartan—Pollakiuria—Doxorubicin—pancreatic cancer	9.01e-05	0.000814	CcSEcCtD
Losartan—Asthenia—Gemcitabine—pancreatic cancer	8.98e-05	0.000812	CcSEcCtD
Losartan—Confusional state—Docetaxel—pancreatic cancer	8.96e-05	0.00081	CcSEcCtD
Losartan—Photosensitivity reaction—Doxorubicin—pancreatic cancer	8.9e-05	0.000804	CcSEcCtD
Losartan—Oedema—Docetaxel—pancreatic cancer	8.88e-05	0.000803	CcSEcCtD
Losartan—Anaphylactic shock—Docetaxel—pancreatic cancer	8.88e-05	0.000803	CcSEcCtD
Losartan—Weight increased—Doxorubicin—pancreatic cancer	8.87e-05	0.000802	CcSEcCtD
Losartan—Epistaxis—Epirubicin—pancreatic cancer	8.86e-05	0.000801	CcSEcCtD
Losartan—Pruritus—Gemcitabine—pancreatic cancer	8.86e-05	0.000801	CcSEcCtD
Losartan—Infection—Docetaxel—pancreatic cancer	8.83e-05	0.000798	CcSEcCtD
Losartan—Sinusitis—Epirubicin—pancreatic cancer	8.81e-05	0.000797	CcSEcCtD
Losartan—Hyperglycaemia—Doxorubicin—pancreatic cancer	8.79e-05	0.000795	CcSEcCtD
Losartan—Diarrhoea—Irinotecan—pancreatic cancer	8.79e-05	0.000795	CcSEcCtD
Losartan—Agranulocytosis—Epirubicin—pancreatic cancer	8.77e-05	0.000792	CcSEcCtD
Losartan—Pneumonia—Doxorubicin—pancreatic cancer	8.74e-05	0.00079	CcSEcCtD
Losartan—Shock—Docetaxel—pancreatic cancer	8.74e-05	0.00079	CcSEcCtD
Losartan—Nervous system disorder—Docetaxel—pancreatic cancer	8.71e-05	0.000787	CcSEcCtD
Losartan—Pruritus—Fluorouracil—pancreatic cancer	8.71e-05	0.000787	CcSEcCtD
Losartan—Thrombocytopenia—Docetaxel—pancreatic cancer	8.7e-05	0.000786	CcSEcCtD
Losartan—Tachycardia—Docetaxel—pancreatic cancer	8.67e-05	0.000784	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.62e-05	0.000779	CcSEcCtD
Losartan—Diarrhoea—Gemcitabine—pancreatic cancer	8.56e-05	0.000774	CcSEcCtD
Losartan—Renal failure—Doxorubicin—pancreatic cancer	8.54e-05	0.000772	CcSEcCtD
Losartan—Neuropathy peripheral—Doxorubicin—pancreatic cancer	8.52e-05	0.00077	CcSEcCtD
Losartan—Dizziness—Irinotecan—pancreatic cancer	8.5e-05	0.000768	CcSEcCtD
Losartan—Jaundice—Doxorubicin—pancreatic cancer	8.47e-05	0.000766	CcSEcCtD
Losartan—Anorexia—Docetaxel—pancreatic cancer	8.47e-05	0.000765	CcSEcCtD
Losartan—Rhinitis—Epirubicin—pancreatic cancer	8.45e-05	0.000764	CcSEcCtD
Losartan—Conjunctivitis—Doxorubicin—pancreatic cancer	8.45e-05	0.000764	CcSEcCtD
Losartan—Urinary tract infection—Doxorubicin—pancreatic cancer	8.45e-05	0.000764	CcSEcCtD
Losartan—Hepatitis—Epirubicin—pancreatic cancer	8.43e-05	0.000762	CcSEcCtD
Losartan—Diarrhoea—Fluorouracil—pancreatic cancer	8.42e-05	0.000761	CcSEcCtD
Losartan—Hypoaesthesia—Epirubicin—pancreatic cancer	8.39e-05	0.000758	CcSEcCtD
Losartan—Pharyngitis—Epirubicin—pancreatic cancer	8.37e-05	0.000757	CcSEcCtD
Losartan—Sweating—Doxorubicin—pancreatic cancer	8.33e-05	0.000753	CcSEcCtD
Losartan—Hypotension—Docetaxel—pancreatic cancer	8.3e-05	0.00075	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—pancreatic cancer	8.2e-05	0.000741	CcSEcCtD
Losartan—Vomiting—Irinotecan—pancreatic cancer	8.17e-05	0.000739	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—pancreatic cancer	8.16e-05	0.000737	CcSEcCtD
Losartan—Dizziness—Fluorouracil—pancreatic cancer	8.14e-05	0.000736	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—pancreatic cancer	8.11e-05	0.000733	CcSEcCtD
Losartan—Rash—Irinotecan—pancreatic cancer	8.1e-05	0.000732	CcSEcCtD
Losartan—Dermatitis—Irinotecan—pancreatic cancer	8.09e-05	0.000732	CcSEcCtD
Losartan—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	8.09e-05	0.000732	CcSEcCtD
Losartan—Headache—Irinotecan—pancreatic cancer	8.05e-05	0.000728	CcSEcCtD
Losartan—Insomnia—Docetaxel—pancreatic cancer	8.03e-05	0.000726	CcSEcCtD
Losartan—Paraesthesia—Docetaxel—pancreatic cancer	7.98e-05	0.000721	CcSEcCtD
Losartan—Erythema multiforme—Epirubicin—pancreatic cancer	7.97e-05	0.000721	CcSEcCtD
Losartan—Vomiting—Gemcitabine—pancreatic cancer	7.96e-05	0.000719	CcSEcCtD
Losartan—Dyspnoea—Docetaxel—pancreatic cancer	7.92e-05	0.000716	CcSEcCtD
Losartan—Somnolence—Docetaxel—pancreatic cancer	7.9e-05	0.000714	CcSEcCtD
Losartan—Rash—Gemcitabine—pancreatic cancer	7.89e-05	0.000713	CcSEcCtD
Losartan—Dermatitis—Gemcitabine—pancreatic cancer	7.89e-05	0.000713	CcSEcCtD
Losartan—Tinnitus—Epirubicin—pancreatic cancer	7.86e-05	0.000711	CcSEcCtD
Losartan—Headache—Gemcitabine—pancreatic cancer	7.84e-05	0.000709	CcSEcCtD
Losartan—Flushing—Epirubicin—pancreatic cancer	7.83e-05	0.000707	CcSEcCtD
Losartan—Vomiting—Fluorouracil—pancreatic cancer	7.83e-05	0.000707	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—pancreatic cancer	7.82e-05	0.000707	CcSEcCtD
Losartan—Dyspepsia—Docetaxel—pancreatic cancer	7.82e-05	0.000707	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—pancreatic cancer	7.8e-05	0.000705	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—pancreatic cancer	7.76e-05	0.000702	CcSEcCtD
Losartan—Rash—Fluorouracil—pancreatic cancer	7.76e-05	0.000701	CcSEcCtD
Losartan—Dermatitis—Fluorouracil—pancreatic cancer	7.75e-05	0.000701	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—pancreatic cancer	7.74e-05	0.0007	CcSEcCtD
Losartan—Decreased appetite—Docetaxel—pancreatic cancer	7.72e-05	0.000698	CcSEcCtD
Losartan—Headache—Fluorouracil—pancreatic cancer	7.71e-05	0.000697	CcSEcCtD
Losartan—Fatigue—Docetaxel—pancreatic cancer	7.66e-05	0.000692	CcSEcCtD
Losartan—Angiopathy—Epirubicin—pancreatic cancer	7.65e-05	0.000692	CcSEcCtD
Losartan—Nausea—Irinotecan—pancreatic cancer	7.63e-05	0.00069	CcSEcCtD
Losartan—Constipation—Docetaxel—pancreatic cancer	7.6e-05	0.000687	CcSEcCtD
Losartan—Pain—Docetaxel—pancreatic cancer	7.6e-05	0.000687	CcSEcCtD
Losartan—Arrhythmia—Epirubicin—pancreatic cancer	7.53e-05	0.000681	CcSEcCtD
Losartan—Alopecia—Epirubicin—pancreatic cancer	7.45e-05	0.000674	CcSEcCtD
Losartan—Nausea—Gemcitabine—pancreatic cancer	7.44e-05	0.000672	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—pancreatic cancer	7.38e-05	0.000667	CcSEcCtD
Losartan—Erythema—Epirubicin—pancreatic cancer	7.34e-05	0.000664	CcSEcCtD
Losartan—Feeling abnormal—Docetaxel—pancreatic cancer	7.32e-05	0.000662	CcSEcCtD
Losartan—Nausea—Fluorouracil—pancreatic cancer	7.31e-05	0.000661	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—pancreatic cancer	7.28e-05	0.000658	CcSEcCtD
Losartan—Gastrointestinal pain—Docetaxel—pancreatic cancer	7.26e-05	0.000657	CcSEcCtD
Losartan—Flushing—Doxorubicin—pancreatic cancer	7.24e-05	0.000655	CcSEcCtD
Losartan—Flatulence—Epirubicin—pancreatic cancer	7.23e-05	0.000654	CcSEcCtD
Losartan—Tension—Epirubicin—pancreatic cancer	7.2e-05	0.000651	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—pancreatic cancer	7.19e-05	0.00065	CcSEcCtD
Losartan—Nervousness—Epirubicin—pancreatic cancer	7.13e-05	0.000645	CcSEcCtD
Losartan—Back pain—Epirubicin—pancreatic cancer	7.1e-05	0.000642	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—pancreatic cancer	7.08e-05	0.00064	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—pancreatic cancer	7.06e-05	0.000638	CcSEcCtD
Losartan—Abdominal pain—Docetaxel—pancreatic cancer	7.02e-05	0.000635	CcSEcCtD
Losartan—Body temperature increased—Docetaxel—pancreatic cancer	7.02e-05	0.000635	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—pancreatic cancer	6.97e-05	0.00063	CcSEcCtD
Losartan—Vision blurred—Epirubicin—pancreatic cancer	6.92e-05	0.000625	CcSEcCtD
Losartan—Alopecia—Doxorubicin—pancreatic cancer	6.9e-05	0.000623	CcSEcCtD
Losartan—Ill-defined disorder—Epirubicin—pancreatic cancer	6.81e-05	0.000616	CcSEcCtD
Losartan—Erythema—Doxorubicin—pancreatic cancer	6.79e-05	0.000614	CcSEcCtD
Losartan—Anaemia—Epirubicin—pancreatic cancer	6.79e-05	0.000613	CcSEcCtD
Losartan—Agitation—Epirubicin—pancreatic cancer	6.75e-05	0.00061	CcSEcCtD
Losartan—Flatulence—Doxorubicin—pancreatic cancer	6.69e-05	0.000605	CcSEcCtD
Losartan—Tension—Doxorubicin—pancreatic cancer	6.67e-05	0.000603	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—pancreatic cancer	6.65e-05	0.000601	CcSEcCtD
Losartan—Malaise—Epirubicin—pancreatic cancer	6.62e-05	0.000598	CcSEcCtD
Losartan—Nervousness—Doxorubicin—pancreatic cancer	6.6e-05	0.000596	CcSEcCtD
Losartan—Vertigo—Epirubicin—pancreatic cancer	6.6e-05	0.000596	CcSEcCtD
Losartan—Syncope—Epirubicin—pancreatic cancer	6.58e-05	0.000595	CcSEcCtD
Losartan—Leukopenia—Epirubicin—pancreatic cancer	6.57e-05	0.000594	CcSEcCtD
Losartan—Back pain—Doxorubicin—pancreatic cancer	6.57e-05	0.000594	CcSEcCtD
Losartan—Hypersensitivity—Docetaxel—pancreatic cancer	6.54e-05	0.000592	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—pancreatic cancer	6.53e-05	0.00059	CcSEcCtD
Losartan—Palpitations—Epirubicin—pancreatic cancer	6.49e-05	0.000586	CcSEcCtD
Losartan—Loss of consciousness—Epirubicin—pancreatic cancer	6.45e-05	0.000583	CcSEcCtD
Losartan—Cough—Epirubicin—pancreatic cancer	6.41e-05	0.000579	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—pancreatic cancer	6.4e-05	0.000579	CcSEcCtD
Losartan—Asthenia—Docetaxel—pancreatic cancer	6.37e-05	0.000576	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—pancreatic cancer	6.3e-05	0.00057	CcSEcCtD
Losartan—Pruritus—Docetaxel—pancreatic cancer	6.28e-05	0.000568	CcSEcCtD
Losartan—Anaemia—Doxorubicin—pancreatic cancer	6.28e-05	0.000568	CcSEcCtD
Losartan—Myalgia—Epirubicin—pancreatic cancer	6.25e-05	0.000565	CcSEcCtD
Losartan—Chest pain—Epirubicin—pancreatic cancer	6.25e-05	0.000565	CcSEcCtD
Losartan—Arthralgia—Epirubicin—pancreatic cancer	6.25e-05	0.000565	CcSEcCtD
Losartan—Agitation—Doxorubicin—pancreatic cancer	6.24e-05	0.000564	CcSEcCtD
Losartan—Anxiety—Epirubicin—pancreatic cancer	6.23e-05	0.000563	CcSEcCtD
Losartan—Discomfort—Epirubicin—pancreatic cancer	6.18e-05	0.000558	CcSEcCtD
Losartan—Malaise—Doxorubicin—pancreatic cancer	6.13e-05	0.000554	CcSEcCtD
Losartan—Dry mouth—Epirubicin—pancreatic cancer	6.11e-05	0.000553	CcSEcCtD
Losartan—Vertigo—Doxorubicin—pancreatic cancer	6.1e-05	0.000552	CcSEcCtD
Losartan—Syncope—Doxorubicin—pancreatic cancer	6.09e-05	0.000551	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—pancreatic cancer	6.08e-05	0.00055	CcSEcCtD
Losartan—Diarrhoea—Docetaxel—pancreatic cancer	6.08e-05	0.000549	CcSEcCtD
Losartan—Confusional state—Epirubicin—pancreatic cancer	6.04e-05	0.000546	CcSEcCtD
Losartan—Palpitations—Doxorubicin—pancreatic cancer	6e-05	0.000543	CcSEcCtD
Losartan—Oedema—Epirubicin—pancreatic cancer	5.99e-05	0.000542	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—pancreatic cancer	5.99e-05	0.000542	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—pancreatic cancer	5.97e-05	0.00054	CcSEcCtD
Losartan—Infection—Epirubicin—pancreatic cancer	5.95e-05	0.000538	CcSEcCtD
Losartan—Cough—Doxorubicin—pancreatic cancer	5.93e-05	0.000536	CcSEcCtD
Losartan—Shock—Epirubicin—pancreatic cancer	5.89e-05	0.000533	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—pancreatic cancer	5.88e-05	0.000531	CcSEcCtD
Losartan—Dizziness—Docetaxel—pancreatic cancer	5.87e-05	0.000531	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—pancreatic cancer	5.87e-05	0.00053	CcSEcCtD
Losartan—Tachycardia—Epirubicin—pancreatic cancer	5.85e-05	0.000529	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—pancreatic cancer	5.79e-05	0.000524	CcSEcCtD
Losartan—Chest pain—Doxorubicin—pancreatic cancer	5.78e-05	0.000523	CcSEcCtD
Losartan—Myalgia—Doxorubicin—pancreatic cancer	5.78e-05	0.000523	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—pancreatic cancer	5.78e-05	0.000523	CcSEcCtD
Losartan—Anxiety—Doxorubicin—pancreatic cancer	5.76e-05	0.000521	CcSEcCtD
Losartan—Discomfort—Doxorubicin—pancreatic cancer	5.71e-05	0.000516	CcSEcCtD
Losartan—Anorexia—Epirubicin—pancreatic cancer	5.71e-05	0.000516	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—pancreatic cancer	5.66e-05	0.000511	CcSEcCtD
Losartan—Vomiting—Docetaxel—pancreatic cancer	5.65e-05	0.000511	CcSEcCtD
Losartan—Rash—Docetaxel—pancreatic cancer	5.6e-05	0.000506	CcSEcCtD
Losartan—Hypotension—Epirubicin—pancreatic cancer	5.6e-05	0.000506	CcSEcCtD
Losartan—Dermatitis—Docetaxel—pancreatic cancer	5.6e-05	0.000506	CcSEcCtD
Losartan—Confusional state—Doxorubicin—pancreatic cancer	5.59e-05	0.000505	CcSEcCtD
Losartan—Headache—Docetaxel—pancreatic cancer	5.56e-05	0.000503	CcSEcCtD
Losartan—Oedema—Doxorubicin—pancreatic cancer	5.54e-05	0.000501	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—pancreatic cancer	5.54e-05	0.000501	CcSEcCtD
Losartan—Infection—Doxorubicin—pancreatic cancer	5.51e-05	0.000498	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.46e-05	0.000493	CcSEcCtD
Losartan—Shock—Doxorubicin—pancreatic cancer	5.45e-05	0.000493	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—pancreatic cancer	5.44e-05	0.000491	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—pancreatic cancer	5.43e-05	0.000491	CcSEcCtD
Losartan—Insomnia—Epirubicin—pancreatic cancer	5.42e-05	0.00049	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—pancreatic cancer	5.41e-05	0.000489	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—pancreatic cancer	5.38e-05	0.000486	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.36e-05	0.000484	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—pancreatic cancer	5.34e-05	0.000483	CcSEcCtD
Losartan—Somnolence—Epirubicin—pancreatic cancer	5.33e-05	0.000481	CcSEcCtD
Losartan—Anorexia—Doxorubicin—pancreatic cancer	5.28e-05	0.000478	CcSEcCtD
Losartan—Nausea—Docetaxel—pancreatic cancer	5.28e-05	0.000477	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—pancreatic cancer	5.27e-05	0.000477	CcSEcCtD
Losartan—Decreased appetite—Epirubicin—pancreatic cancer	5.21e-05	0.000471	CcSEcCtD
Losartan—Hypotension—Doxorubicin—pancreatic cancer	5.18e-05	0.000468	CcSEcCtD
Losartan—Fatigue—Epirubicin—pancreatic cancer	5.17e-05	0.000467	CcSEcCtD
Losartan—Pain—Epirubicin—pancreatic cancer	5.12e-05	0.000463	CcSEcCtD
Losartan—Constipation—Epirubicin—pancreatic cancer	5.12e-05	0.000463	CcSEcCtD
Losartan—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.05e-05	0.000457	CcSEcCtD
Losartan—Insomnia—Doxorubicin—pancreatic cancer	5.01e-05	0.000453	CcSEcCtD
Losartan—Paraesthesia—Doxorubicin—pancreatic cancer	4.98e-05	0.00045	CcSEcCtD
Losartan—Dyspnoea—Doxorubicin—pancreatic cancer	4.94e-05	0.000447	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—pancreatic cancer	4.94e-05	0.000446	CcSEcCtD
Losartan—Somnolence—Doxorubicin—pancreatic cancer	4.93e-05	0.000445	CcSEcCtD
Losartan—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.9e-05	0.000443	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—pancreatic cancer	4.88e-05	0.000441	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—pancreatic cancer	4.82e-05	0.000436	CcSEcCtD
Losartan—Fatigue—Doxorubicin—pancreatic cancer	4.78e-05	0.000432	CcSEcCtD
Losartan—Urticaria—Epirubicin—pancreatic cancer	4.76e-05	0.00043	CcSEcCtD
Losartan—Constipation—Doxorubicin—pancreatic cancer	4.74e-05	0.000429	CcSEcCtD
Losartan—Pain—Doxorubicin—pancreatic cancer	4.74e-05	0.000429	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—pancreatic cancer	4.74e-05	0.000428	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—pancreatic cancer	4.74e-05	0.000428	CcSEcCtD
Losartan—Feeling abnormal—Doxorubicin—pancreatic cancer	4.57e-05	0.000413	CcSEcCtD
Losartan—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.53e-05	0.00041	CcSEcCtD
Losartan—Hypersensitivity—Epirubicin—pancreatic cancer	4.41e-05	0.000399	CcSEcCtD
Losartan—Urticaria—Doxorubicin—pancreatic cancer	4.4e-05	0.000398	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—pancreatic cancer	4.38e-05	0.000396	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—pancreatic cancer	4.38e-05	0.000396	CcSEcCtD
Losartan—Asthenia—Epirubicin—pancreatic cancer	4.3e-05	0.000389	CcSEcCtD
Losartan—Pruritus—Epirubicin—pancreatic cancer	4.24e-05	0.000383	CcSEcCtD
Losartan—Diarrhoea—Epirubicin—pancreatic cancer	4.1e-05	0.000371	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—pancreatic cancer	4.08e-05	0.000369	CcSEcCtD
Losartan—Asthenia—Doxorubicin—pancreatic cancer	3.98e-05	0.00036	CcSEcCtD
Losartan—Dizziness—Epirubicin—pancreatic cancer	3.96e-05	0.000358	CcSEcCtD
Losartan—Pruritus—Doxorubicin—pancreatic cancer	3.92e-05	0.000355	CcSEcCtD
Losartan—Vomiting—Epirubicin—pancreatic cancer	3.81e-05	0.000344	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—pancreatic cancer	3.79e-05	0.000343	CcSEcCtD
Losartan—Rash—Epirubicin—pancreatic cancer	3.78e-05	0.000341	CcSEcCtD
Losartan—Dermatitis—Epirubicin—pancreatic cancer	3.77e-05	0.000341	CcSEcCtD
Losartan—Headache—Epirubicin—pancreatic cancer	3.75e-05	0.000339	CcSEcCtD
Losartan—Dizziness—Doxorubicin—pancreatic cancer	3.67e-05	0.000331	CcSEcCtD
Losartan—Nausea—Epirubicin—pancreatic cancer	3.56e-05	0.000322	CcSEcCtD
Losartan—Vomiting—Doxorubicin—pancreatic cancer	3.52e-05	0.000319	CcSEcCtD
Losartan—Rash—Doxorubicin—pancreatic cancer	3.5e-05	0.000316	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—pancreatic cancer	3.49e-05	0.000316	CcSEcCtD
Losartan—Headache—Doxorubicin—pancreatic cancer	3.47e-05	0.000314	CcSEcCtD
Losartan—Nausea—Doxorubicin—pancreatic cancer	3.29e-05	0.000298	CcSEcCtD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	8.05e-06	0.000186	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ARG2—pancreatic cancer	8.04e-06	0.000186	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—DPYD—pancreatic cancer	8.01e-06	0.000185	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	7.98e-06	0.000185	CbGpPWpGaD
Losartan—ALB—Metabolism—DPYD—pancreatic cancer	7.97e-06	0.000184	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TYMS—pancreatic cancer	7.94e-06	0.000184	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CG—pancreatic cancer	7.83e-06	0.000181	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CD—pancreatic cancer	7.63e-06	0.000176	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	7.6e-06	0.000176	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—EGFR—pancreatic cancer	7.58e-06	0.000175	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC2A2—pancreatic cancer	7.56e-06	0.000175	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PPARG—pancreatic cancer	7.56e-06	0.000175	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.52e-06	0.000174	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.48e-06	0.000173	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	7.45e-06	0.000172	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	7.44e-06	0.000172	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	7.33e-06	0.00017	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CD—pancreatic cancer	7.31e-06	0.000169	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GLP1R—pancreatic cancer	7.27e-06	0.000168	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.26e-06	0.000168	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.24e-06	0.000167	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CD—pancreatic cancer	7.22e-06	0.000167	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.22e-06	0.000167	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—KRAS—pancreatic cancer	7.16e-06	0.000166	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PRSS1—pancreatic cancer	7.16e-06	0.000165	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—DPYD—pancreatic cancer	7.15e-06	0.000165	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GLP1R—pancreatic cancer	7.09e-06	0.000164	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	7.09e-06	0.000164	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CB—pancreatic cancer	7.06e-06	0.000163	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—APOE—pancreatic cancer	7.05e-06	0.000163	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TYMP—pancreatic cancer	7.03e-06	0.000162	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGS2—pancreatic cancer	6.99e-06	0.000162	CbGpPWpGaD
Losartan—ABCB1—Metabolism—DPYD—pancreatic cancer	6.98e-06	0.000161	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CD—pancreatic cancer	6.88e-06	0.000159	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CD44—pancreatic cancer	6.8e-06	0.000157	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	6.79e-06	0.000157	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.79e-06	0.000157	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.72e-06	0.000155	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CB—pancreatic cancer	6.65e-06	0.000154	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GLP1R—pancreatic cancer	6.63e-06	0.000153	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC2A2—pancreatic cancer	6.62e-06	0.000153	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.61e-06	0.000153	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGS2—pancreatic cancer	6.59e-06	0.000152	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.58e-06	0.000152	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PIK3CA—pancreatic cancer	6.58e-06	0.000152	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—DPYD—pancreatic cancer	6.52e-06	0.000151	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GCG—pancreatic cancer	6.52e-06	0.000151	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.48e-06	0.00015	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—APOE—pancreatic cancer	6.46e-06	0.000149	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CB—pancreatic cancer	6.37e-06	0.000147	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CG—pancreatic cancer	6.36e-06	0.000147	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CB—pancreatic cancer	6.3e-06	0.000146	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ARG2—pancreatic cancer	6.2e-06	0.000143	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	6.19e-06	0.000143	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PPARG—pancreatic cancer	6.14e-06	0.000142	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—STK11—pancreatic cancer	6.13e-06	0.000142	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL8—pancreatic cancer	6.12e-06	0.000142	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.12e-06	0.000142	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	6.12e-06	0.000141	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTEN—pancreatic cancer	6.1e-06	0.000141	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—pancreatic cancer	6.08e-06	0.000141	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	6.08e-06	0.000141	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CB—pancreatic cancer	6e-06	0.000139	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.99e-06	0.000139	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—pancreatic cancer	5.95e-06	0.000137	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—pancreatic cancer	5.92e-06	0.000137	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.91e-06	0.000137	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.9e-06	0.000137	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CD44—pancreatic cancer	5.89e-06	0.000136	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CASP3—pancreatic cancer	5.86e-06	0.000136	CbGpPWpGaD
Losartan—ALB—Metabolism—CD44—pancreatic cancer	5.85e-06	0.000135	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	5.83e-06	0.000135	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.8e-06	0.000134	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.77e-06	0.000133	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTEN—pancreatic cancer	5.75e-06	0.000133	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.73e-06	0.000133	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.71e-06	0.000132	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CCND1—pancreatic cancer	5.71e-06	0.000132	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.68e-06	0.000131	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GLP1R—pancreatic cancer	5.66e-06	0.000131	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CTNNB1—pancreatic cancer	5.65e-06	0.000131	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GCG—pancreatic cancer	5.64e-06	0.000131	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPARG—pancreatic cancer	5.63e-06	0.00013	CbGpPWpGaD
Losartan—ALB—Metabolism—GCG—pancreatic cancer	5.61e-06	0.00013	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CD—pancreatic cancer	5.59e-06	0.000129	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—DPYD—pancreatic cancer	5.57e-06	0.000129	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—pancreatic cancer	5.54e-06	0.000128	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTEN—pancreatic cancer	5.51e-06	0.000127	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TYMP—pancreatic cancer	5.42e-06	0.000125	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.38e-06	0.000124	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—pancreatic cancer	5.37e-06	0.000124	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—STK11—pancreatic cancer	5.31e-06	0.000123	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	5.29e-06	0.000122	CbGpPWpGaD
Losartan—ALB—Metabolism—STK11—pancreatic cancer	5.28e-06	0.000122	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TYMS—pancreatic cancer	5.27e-06	0.000122	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CD44—pancreatic cancer	5.26e-06	0.000122	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.23e-06	0.000121	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTEN—pancreatic cancer	5.19e-06	0.00012	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.15e-06	0.000119	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CD44—pancreatic cancer	5.13e-06	0.000119	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	5.13e-06	0.000119	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SRC—pancreatic cancer	5.11e-06	0.000118	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.1e-06	0.000118	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.05e-06	0.000117	CbGpPWpGaD
Losartan—ALB—Hemostasis—SRC—pancreatic cancer	5.05e-06	0.000117	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GCG—pancreatic cancer	5.04e-06	0.000117	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.98e-06	0.000115	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—pancreatic cancer	4.97e-06	0.000115	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.95e-06	0.000115	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—STAT3—pancreatic cancer	4.93e-06	0.000114	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GCG—pancreatic cancer	4.92e-06	0.000114	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—pancreatic cancer	4.91e-06	0.000114	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRAS—pancreatic cancer	4.91e-06	0.000114	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CB—pancreatic cancer	4.88e-06	0.000113	CbGpPWpGaD
Losartan—ALB—Hemostasis—NRAS—pancreatic cancer	4.85e-06	0.000112	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—pancreatic cancer	4.83e-06	0.000112	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CD44—pancreatic cancer	4.79e-06	0.000111	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—STK11—pancreatic cancer	4.74e-06	0.00011	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.69e-06	0.000108	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.65e-06	0.000108	CbGpPWpGaD
Losartan—ABCB1—Metabolism—STK11—pancreatic cancer	4.62e-06	0.000107	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.6e-06	0.000106	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GCG—pancreatic cancer	4.59e-06	0.000106	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—pancreatic cancer	4.58e-06	0.000106	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—pancreatic cancer	4.57e-06	0.000106	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TYMS—pancreatic cancer	4.57e-06	0.000106	CbGpPWpGaD
Losartan—ALB—Metabolism—TYMS—pancreatic cancer	4.54e-06	0.000105	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—pancreatic cancer	4.51e-06	0.000104	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—EGFR—pancreatic cancer	4.48e-06	0.000104	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	4.47e-06	0.000103	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.45e-06	0.000103	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	4.43e-06	0.000102	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.37e-06	0.000101	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—STK11—pancreatic cancer	4.32e-06	9.99e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PIK3CA—pancreatic cancer	4.3e-06	9.95e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.3e-06	9.94e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—APOE—pancreatic cancer	4.29e-06	9.91e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KRAS—pancreatic cancer	4.23e-06	9.78e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTEN—pancreatic cancer	4.21e-06	9.74e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—KRAS—pancreatic cancer	4.18e-06	9.66e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CD44—pancreatic cancer	4.09e-06	9.47e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.08e-06	9.44e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TYMS—pancreatic cancer	4.07e-06	9.42e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.05e-06	9.38e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PIK3CA—pancreatic cancer	4.05e-06	9.37e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.01e-06	9.27e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TYMS—pancreatic cancer	3.98e-06	9.2e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.97e-06	9.19e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GCG—pancreatic cancer	3.93e-06	9.08e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PIK3CA—pancreatic cancer	3.88e-06	8.98e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	3.87e-06	8.95e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTEN—pancreatic cancer	3.86e-06	8.93e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—PIK3CA—pancreatic cancer	3.84e-06	8.88e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—pancreatic cancer	3.76e-06	8.69e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARG—pancreatic cancer	3.73e-06	8.63e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TYMS—pancreatic cancer	3.72e-06	8.59e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—pancreatic cancer	3.71e-06	8.59e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—APOE—pancreatic cancer	3.71e-06	8.59e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—APOE—pancreatic cancer	3.69e-06	8.54e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—STK11—pancreatic cancer	3.69e-06	8.53e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PIK3CA—pancreatic cancer	3.66e-06	8.46e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—pancreatic cancer	3.59e-06	8.31e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—pancreatic cancer	3.55e-06	8.21e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.51e-06	8.13e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—pancreatic cancer	3.51e-06	8.13e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.49e-06	8.08e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.46e-06	8.01e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	3.4e-06	7.86e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	3.35e-06	7.75e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CG—pancreatic cancer	3.33e-06	7.7e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—APOE—pancreatic cancer	3.31e-06	7.66e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—pancreatic cancer	3.31e-06	7.66e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—APOE—pancreatic cancer	3.23e-06	7.48e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARG—pancreatic cancer	3.23e-06	7.48e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARG—pancreatic cancer	3.22e-06	7.44e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TYMS—pancreatic cancer	3.17e-06	7.34e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—pancreatic cancer	3.17e-06	7.34e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CD44—pancreatic cancer	3.16e-06	7.31e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.14e-06	7.25e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—pancreatic cancer	3.14e-06	7.25e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GCG—pancreatic cancer	3.03e-06	7.01e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—APOE—pancreatic cancer	3.02e-06	6.99e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.99e-06	6.92e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—pancreatic cancer	2.99e-06	6.91e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PIK3CA—pancreatic cancer	2.97e-06	6.87e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	2.96e-06	6.85e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	2.95e-06	6.81e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—pancreatic cancer	2.94e-06	6.79e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CD—pancreatic cancer	2.93e-06	6.77e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.92e-06	6.75e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.89e-06	6.67e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.86e-06	6.61e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—STK11—pancreatic cancer	2.85e-06	6.59e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARG—pancreatic cancer	2.82e-06	6.51e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	2.73e-06	6.31e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	2.72e-06	6.3e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARG—pancreatic cancer	2.63e-06	6.09e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.63e-06	6.08e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—APOE—pancreatic cancer	2.58e-06	5.97e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	2.57e-06	5.94e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.57e-06	5.93e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTEN—pancreatic cancer	2.56e-06	5.92e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CB—pancreatic cancer	2.55e-06	5.9e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—pancreatic cancer	2.54e-06	5.88e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—pancreatic cancer	2.53e-06	5.85e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.45e-06	5.67e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.44e-06	5.65e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—pancreatic cancer	2.43e-06	5.61e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	2.4e-06	5.54e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.33e-06	5.39e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.29e-06	5.3e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.27e-06	5.25e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARG—pancreatic cancer	2.25e-06	5.2e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CB—pancreatic cancer	2.24e-06	5.17e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—pancreatic cancer	2.23e-06	5.15e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTEN—pancreatic cancer	2.22e-06	5.13e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—pancreatic cancer	2.22e-06	5.12e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PTEN—pancreatic cancer	2.21e-06	5.1e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.09e-06	4.83e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.07e-06	4.79e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.05e-06	4.74e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—APOE—pancreatic cancer	1.99e-06	4.61e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.98e-06	4.58e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTEN—pancreatic cancer	1.93e-06	4.47e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	1.81e-06	4.18e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTEN—pancreatic cancer	1.81e-06	4.18e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.8e-06	4.16e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.79e-06	4.13e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.77e-06	4.09e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.74e-06	4.01e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.58e-06	3.66e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	1.57e-06	3.62e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PIK3CA—pancreatic cancer	1.56e-06	3.6e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.54e-06	3.57e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.48e-06	3.41e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.4e-06	3.23e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.38e-06	3.19e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.37e-06	3.16e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.36e-06	3.15e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—pancreatic cancer	1.28e-06	2.96e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.27e-06	2.95e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—pancreatic cancer	1.27e-06	2.94e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.19e-06	2.75e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.14e-06	2.64e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—pancreatic cancer	1.11e-06	2.58e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.09e-06	2.52e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.04e-06	2.41e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—pancreatic cancer	8.89e-07	2.06e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	8.4e-07	1.94e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—pancreatic cancer	6.86e-07	1.59e-05	CbGpPWpGaD
